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ABSTRACT 
A prospective cohort study was conducted during a 15-month 
period to compare nosocomial infections (NIs) among pediatric 
patients without (n = 989) and with (n = 50) symptomatic human 
immunodeficiency virus (HIV) infection. Patients with symptomatic 
HIV infection presented higher overall NI incidence density rates 
(relative risk, 1.65; P = .0001), and may represent a population at high 
risk for the acquisition of NI (Infect Control Hosp Epidemiol 2002;23: 
689-692). 
As of September 1999, 5,778 cases of human immun-
odeficiency virus (HIV) had been reported among children 
13 years or younger in Brazil, for a cumulative incidence of 
117.6 cases per 100,000 population.1 Individuals with 
advanced HIV infection or with acquired immunodeficien-
cy syndrome (AIDS) may be more prone to nosocomial 
infections (NIs), given the underlying immunodeficiency, 
frequency of hospital admissions, increased length of stay, 
frequent use of invasive devices, and treatment with broad-
spectrum antimicrobials.2 Studies evaluating adults with 
HIV infection or AIDS have indicated that NIs are more fre-
quent among these patients compared with adults not 
infected with HIV.3"6 To the best of our knowledge, there 
are no published studies that have attempted to evaluate 
rates of NIs among symptomatic HIV-infected pediatric 
patients. 
METHODS 
Setting 
The Institute de Puericultura e Pediatria Martagao 
Gesteira is a 55-bed, pediatric university hospital. Since 
1988, it has been an AIDS referral center to which children 
found to be HIV positive at other institutions in the city of 
Rio de Janeiro are referred. 
Definitions and Diagnostic Criteria 
The study period was defined as May 1,1995, to July 
31, 1996. All patients admitted to the Institute de 
Puericultura e Pediatria Martagao Gesteira during the 
study period were included. NIs were classified by the 
Centers for Disease Control and Prevention definitions.7 A 
case of symptomatic HIV infection was defined according 
to the 1994 Pan American Health Organization pediatric 
AIDS case definition,8 and had to meet one of the following 
criteria: 
1. Presence of at least one major sign: Pneumocystis 
carinii pneumonia, candidiasis of the esophagus, lymphoid 
interstitial pneumonitis, Kaposi sarcoma, or parotid hyper-
trophy. 
2. Presence of two or more characteristic manifesta-
tions: recurrent bacterial and viral infections (two or more 
severe infections, such as sepsis, pneumonia, osteo-
myelitis, or meningitis) during a 2-year period; Myco-
bacterium tuberculosis disease (miliary or extrapulmonary); 
disseminated varicella zoster; disseminated Cyto-
megalovirus infection; or neurologic manifestations (devel-
opmental delay, progressive encephalopathy, micro-
cephaly, or neuroradiographic abnormalities). 
3. Presence of at least one characteristic manifes-
tation and two or more associated signs, defined as 
oropharyngeal candidiasis, failure to thrive, prolonged 
fever for more than 1 month (intermittent or constant), 
generalized lymphadenopathy, hepatomegaly, or spleno-
megaly. 
4. Presence of three or more associated signs and 
an epidemiologic risk factor, defined as being born to a 
mother who was HIV positive, used intravenous drugs, or 
had sexual contact with intravenous drug users or HIV-pos-
itive men; being a victim of sexual abuse; or having 
received blood or blood products before 1985. 
5. Presence of HIV-positive serology and one char-
acteristic manifestation or two or more associated signs. 
Death was defined as related to NI according to the 
following criteria: (1) cause of death—the NI was not under 
control at the time of death or was under control but the 
consequences of infection were sufficient to cause death; 
(2) related to or associated with death—the underlying dis-
ease was directly responsible for the outcome, despite the 
existence and contribution of active infections; and (3) not 
related to death—the morbidity associated with the under-
lying illness was clearly more severe than the infectious 
process and capable of directly causing death. 
Data Collection 
Data on NI and HIV infection were prospectively col-
lected through an active surveillance system conducted by 
members of the hospital infection control team, who visited 
each ward three times a week. All admitted patients were 
observed until discharge. Whenever HIV infection was sus-
pected, standard serologic tests for HIV were performed 
(enzyme-linked immunosorbent assay and Western blot). 
Patients whose serologic status could not be ensured were 
excluded. 
For each patient, the following variables were col-
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TABLE 1 
DISTRIBUTION OF DIAGNOSES AT ADMISSION AMONG 1,316 PATIENTS ADMITTED TO THE INSTITUTO DE PUERICULTURA E PEDIATRIA 
MARTAGAO GESTEIRA, FEDERAL UNIVERSITY OF RIO DE JANEIRO, BRAZIL, FROM MAY 1,1995, TO JULY 31, 1996 
Diagnosis Group I* (%) Group ir (%) 
Respiratory tract diseases 
Infectious diseases 
Neoplasias 
Gastrointestinal diseases 
Bone, joint, and connective tissue diseases 
Neurologic diseases 
Hematologic diseases 
Cardiovascular diseases 
Genitourinary diseases 
Skin and subcutaneous tissue diseases 
Dismorphologic and chromosomal diseases 
Endocrinologic, nutritional, and metabolic diseases 
Ear and mastoid diseases 
Eye diseases 
Others 
Total 
326 
261 
142 
118 
106 
85 
75 
71 
65 
62 
57 
46 
34 
4 
61 
1,513 
(21.5) 
(17.3) 
(9.4) 
(7.8) 
(7.0) 
(5.6) 
(5.0) 
(4.7) 
(4.3) 
(4.1) 
(3.8) 
(3.0) 
(2.2) 
(0.3) 
(4.0) 
(100) 
55 
21 
6 
28 
_ 
3 
2 
1 
2 
5 
— 
20 
26 
— 
4 
173 
(31.7) 
(12.1) 
(3.5) 
(16.1) 
— 
(1.7) 
(1.2) 
(0.6) 
(1.2) 
(2.9) 
— 
(11.6) 
(15.0) 
— 
(2.4) 
(100) 
.002 
.084 
.009 
<.001 
<.001 
.030 
.022 
.011 
.045 
.441 
.009 
<.001 
<.001 
— 
.563 
— 
"Patients without symptomatic human immunodeficiency virus. 
tPatients with symptomatic human immunodeficiency virus. 
lected: gender, age, admission diagnoses, site of hospital 
infection, and dates of admission and discharge, date of 
transfer to another hospital, or date of death. For patients 
with symptomatic HIV, CD4 cell counts (at admission or in 
the previous 6 months) were also collected. 
Data Analysis 
All data were entered into Epi-Info software (version 
6.04b; Centers for Disease Control and Prevention, Atlanta, 
GA). Categorical variables were analyzed using the chi-
square or Fisher's exact test (two-tailed). The Student's t 
test or the Mann-Whitney test was used when appropriate. 
The NI mortality rate was calculated by dividing the num-
ber of patients with deaths related to NI by the total num-
ber of patient admissions during the study period and mul-
tiplying by 100. 
RESULTS 
Between May 1,1995, and July 31,1996, there were 
1,316 hospital admissions among 1,039 patients. The dis-
tribution of diagnoses at admission is shown in Table 1. 
There were 1,228 admissions identified among 989 
patients without symptomatic HIV infection (group I) and 
88 among 50 patients with symptomatic HIV infection 
(group II) for a total of 19,726 patient-days. Of these, 1,832 
were in group II (9.9%). The mean number of hospital 
admissions per patient was 1.24 for group I and 1.76 for 
group II (P = .002). The median age of the patients with 
symptomatic HIV infection was significantly higher (51 
months [range, 39 days to 14 years] vs 37.8 months 
[range, 3 days to 16 years, 7 months]; P = .012). There was 
no difference in gender distribution between the two 
groups (54% of the patients in group I vs 53% of the 
patients in group II were male). 
Among patients in group II, 36 (72%) were already 
known to be infected with HIV on admission. Serologic test-
ing for HIV was performed among 235 patients with no 
prior diagnosis of HIV infection on admission. Twenty of 
these patients tested positive, with 14 fulfilling Pan 
American Health Organization criteria for symptomatic 
HIV infection during hospitalization. 
NIs 
There were 568 NIs, of which 486 occurred in 
group I (86.6%) and 82 in group II (14.4%). NIs occurred 
in 21.4% (263 of 1,228) of the admissions in group I and in 
36.4% (32 of 88) of the admissions in group II (P = .001). 
The number of NIs per patient was also higher in group II 
(0.49 vs 1.64, respectively; P< .001). The median length of 
hospital stay prior to NI was 7 days for group I (range, 2 
to 68 days) and 9 days for group II (range, 3 to 39 days) 
(P=.30). 
The global cumulative incidences were 40.74 and 
98.80 NIs per 100 discharges for groups I and II, respec-
tively (P < .001). Overall incidence densities of NI were 
27.15 and 44.76 NIs per 1,000 patient-days for groups I and 
II, respectively (relative risk, 1.65; 95% confidence interval 
[CI95], 1.30 to 2.08; P = .0001). The incidence density of NI 
was higher in group II even after stratification for age, and 
for the following sites: digestive tract, oral cavity, and sinus-
es (Table 2). We performed a second analysis, excluding 
these three sites from both groups. In this second analysis, 
no significant difference in the incidence density was found 
between the two groups: 21.91 versus 27.29 NIs per 1,000 
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TABLE 2 
INCIDENCE DENSITY OF NOSOCOMIAL INFECTIONS AMONG 1,316 PATIENTS WITH SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS AND 
WITHOUT SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS AT THE INSTITUTO DE PUERICULTURA E PEDIATRIA MARTAGAO GESTEIRA, 
FEDERAL UNIVERSITY OF R I O DE JANEIRO, BRAZIL, FROM MAY 1,1995, TO JULY 31, 1996 
Site of NI 
Incidence* (No.) 
Group lf Group II* RR (Cl„) 
Vascular 
Bloodstream 
Respiratory tract 
Skin 
Gastrointestinal 
Oral cavity 
Ear and mastoid 
Sinuses 
Eye 
Systemic 
Urinary tract 
Central nervous system 
Myocarditis 
Surgical site 
Total 
3.30 
3.74 
6.87 
4.25 
2.57 
2.40 
1.51 
0.28 
0.50 
0.34 
0.28 
0.22 
— 
0.89 
27.16 
(59) 
(67) 
(123) 
(76) 
(46) 
(43) 
(27) 
(5) 
(9) 
(6) 
(5) 
(4) 
(16) 
(486) 
6.00 
4.91 
6.55 
6.00 
6.55 
9.27 
2.73 
1.64 
0.55 
0.55 
44.76 
(11) 
(9) 
(12) 
(11) 
(12) 
(17) 
(5) 
(3) 
(1) 
(1) 
(82) 
1.82 (0.96 to 3.47) 
1.31 (0.65 to 2.63) 
0.95 (0.53 to 1.72) 
1.41 (0.75 to 2.66) 
2.55 (1.35 to 4.81) 
3.86 (2.20 to 6.77) 
1.81 (0.70 to 4.70) 
5.86 (1.40 to 24.52) 
1.95 (0.23 to 16.72) 
1.65 (1.30 to 2.08) 
NI - nosocomial infection; BR - relative risk; Cl95 - 95% confidence interval. 
*No. of NIs per 1,000 patient-days. 
Patients without symptomatic human immunodeficiency virus, comprising a total of 17.894 patient-days. 
'Patients with symptomatic human immunodeficiency virus, comprising a total of 1.832 patient-days. 
patient-days for groups II and I, respectively (relative risk, 
1.25; CI95, 0.93 to 1.67;P=. 14). 
Laboratory-confirmed bloodstream infection consti-
tuted 38.2% (29 of 76) of the bloodstream infections with 
similar distributions among the two groups (group 1,26 of 
67; group II, 3 of 9). Gram-negative bacilli were the most 
commonly isolated pathogens (24 of 31). 
Characteristics Related to HIV Infection 
The route of HIV acquisition among the 50 patients 
with symptomatic HIV was perinatal in 39 (78%) and blood 
transfusion in 5 (10%); in 6 patients (12%), the route of acqui-
sition could not be determined. Seventy-eight (88.6%) symp-
tomatic HIV admissions occurred among children with signs 
or symptoms of severe immunodeficiency.9 Severe CD4 lym-
phopenia was present in 62% of these admissions, ranging 
from 0% to 17% (median, 4%). Absolute numbers of CD4 cells 
ranged from 0 to 460 cells/mm3 (median, 128 cells/mm3). 
No significant association was found between CD4 counts 
and NI presentation in this group. 
Outcome 
The median length of hospital stay was 10 days 
(range, 1 to 210 days) for group I and 14 days (range, 1 to 
122 days) for group II (P = .03). For those patients who 
acquired NI, the hospital stay was longer in both groups 
(8 vs 22 days for group l,P< .001; 9 vs 26.5 days for group 
II, P < .001). Death occurred in 34 (2.8%) of the admis-
sions in group I and in 12 (13.6%) of the admissions in 
group II (P < .001). NIs were considered to be the cause 
of death in 6 patients in group I (3 pneumonia and 3 pri-
mary bloodstream infection) and 2 patients in group II (1 
gastrointestinal and 1 bloodstream infection). NIs were 
indirectly related to death in 1 patient with primary 
bloodstream infection (group I) and 1 patient with gas-
trointestinal infection (group II). The mortality rate relat-
ed to NI was 0.57% in group I and 3.41% in group II (rela-
tive risk, 5.98; CI95, 1.57 to 22.73; P = .025). 
DISCUSSION 
A new hospital population has emerged following the 
HIV epidemic. This population may be at higher risk for 
infections related to the process of care, which can eventu-
ally worsen outcome.2 A similar association has been 
reported among adult patients infected with HIV.3"6 The 
clinical manifestations of symptomatic HIV infection, and 
possibly the epidemiology of NIs, in children are different 
from those in adults. 
The symptomatic HIV group had 2.2 times more fre-
quent NI than did the non-symptomatic HIV group. Similar 
results have been shown in studies involving adults.34 In 
the current study, the duration of hospitalization prior to 
the acquisition of NI was similar to that described by oth-
ers10 and did not differ between the two groups. The three 
NIs for which patients in group II were at higher risk (gas-
trointestinal, oral, and sinusitis) are frequent community-
acquired diseases among HIV-infected pediatric patients 
and their incidence as NI might reflect the natural history 
of AIDS. 
Mortality related to NI was higher among patients 
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with symptomatic HIV, in accordance with other studies in 
adults.5 This finding may suggest that patients with symp-
tomatic HIV could progress more often to death. In terms 
of length of stay, patients who had NI in both groups had a 
significantly more prolonged stay. However, it should be 
emphasized that outcome assessment did not control for 
possible confoundings. 
Patients with symptomatic HIV may be at higher 
risk for NIs and their complications. Advanced anti-retro-
viral treatment approaches have modified the natural his-
tory of HIV infection. A limitation of the current study is 
that these newer approaches were not available in our 
institution at the time the study was conducted. Another 
important limitation is that, because of the small sample 
size, the study might not have had the power to detect sig-
nificant differences in NI rates in sites other than those 
possibly related to the natural history of HIV infection. 
Nonetheless, delineating the epidemiology of NIs among 
pediatric patients with symptomatic HIV may be a useful 
tool for future preventive measures and control of NI in 
this population. 
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Chlorhexidine Resistance in Antibiotic-
Resistant Bacteria Isolated From the 
Surfaces of Dispensers of Soap 
Containing Chlorhexidine 
Steven E. Brooks, PhD; Mary A. Walczak, RN, MS, 
CIC; RizwanuUah Hameed, MD; Patrick Coonan, 
EdD, RN 
ABSTRACT 
Bacterial contamination with pan-resistant Acinetobacter and 
Klebsiella, multidrug-resistant Pseudomonas, and methicillin-resis-
tant Staphylococcus aureus (MRSA) was noted on the surfaces of 
dispensers of hand soap with 2% chlorhexidine. Gram-negative 
isolates could multiply in the presence of 1% chlorhexidine. In con-
trast, MRSA was inhibited in vitro by chlorhexidine at concentra-
tions as low as 0.0019% (Infect Control Hosp Epidemiol 2002;23:692-
695). 
The contamination of dispensers of non-medicated 
soap has been associated with an increased risk of hand 
carriage with the contaminating microorganism.1 We 
describe the surface contamination of dispensers contain-
ing germicidal soap with microorganisms, some of which 
were resistant to the germicidal agent and to most antibi-
otics. 
METHODS 
As part of an investigation into mechanisms of poten-
tial transmission of pan-resistant Acinetobacter, swabs for 
culture were collected from the surfaces of wall-mounted 
dispensers that contained hand soap with 2% chlorhexidine. 
A total of 28 soap dispensers had specimens obtained 
for culture from a variety of clinical and support areas, 
including patient rooms (20), pantries (3), utility rooms (3), 
and staff bathrooms (2). No samples were collected from 
the operating room scrub sinks because these units 
employed a foot pedal dispenser. 
The dispensers were plastic, rectangular, wall-mount-
ed units with a push button for dispensing. The germicidal 
soap was contained in pre-filled disposable bags supplied 
by the manufacturer, which are discarded and replaced 
when empty. No other soap was used in these dispensers. 
The dispensers were scheduled to be cleaned weekly, but 
the significant amount of soap residue found on their 
underside near the dispensing orifice and in crevices 
around the dispensing button raised questions about the 
effectiveness of the cleaning process. 
A single sterile swab moistened with sterile saline was 
used to sample both the area around the soap dispenser 
button and the underside near the dispensing orifice. 
These were areas that could contain a residue of moist soap 
and were areas of hand contact during the process of dis-
pensing the product. No data were collected on the specif-
ic bacterial flora at each site of the dispenser; rather, the 
culture results represent a composite of flora at both sites. 
No hand cultures of staff were performed as part of this 
study. 
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